Schedule 13G ownership disclosure
Fulcrum Therapeutics Inc
Security class unavailable · CUSIP: 359616109
Event date: 2022-03-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,096,890
- Percent of class
- 5.1600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-22-001221
- Form type
- SC 13G
- Filer
- Cowen Financial Products LLC
- CIK
- CIK 1771015
- Filed
- Mar 09, 2022
- Reporting period
- Mar 04, 2022
- Description
- Schedule 13G beneficial ownership